Stockreport

Ironwood Pharmaceuticals Inc (IRWD) Q4 2025 Earnings Call Highlights: Strong LINZESS Sales and ... [Yahoo! Finance]

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com
PDF This article first appeared on GuruFocus LINZESS US Net Sales: $865 million for the full year 2025, with a 13% prescription demand growth in Q4. Adjusted EBITDA: $1 [Read more]